Vinoy Prasad, MD
Interventional Cardiology · Loma Linda, CANPI 1558528372
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Boston Scientific at 54.3% of the total. 2025 is the largest year on record at $6,236, more than ten times the $513 reported in 2019.
Across 118 payments — averaging $116.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$7K
- Shockwave Medical, Inc$2K
- Edwards Lifesciences$1K
- Abiomed$1K
- Abbott$1K
- Medtronic$239
- plus $757 from 9 others
Across 3 payments — averaging $8049.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- M.a. Med Alliance S.A.$24K
- ZOLL Circulation Inc$123
What the payments were for
- Consulting fees$3,12523%
- Grants$1251%
- Travel & lodging$3,07222%
- Food & beverage$7,39254%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 30 | $7,448 |
| Shockwave Medical, Inc | 11 | $1,630 |
| Edwards Lifesciences | 10 | $1,382 |
| Abiomed | 31 | $1,199 |
| Abbott | 22 | $1,058 |
| Medtronic | 4 | $239 |
| Penumbra, Inc. | 1 | $235 |
| Biotronik Inc. | 2 | $153 |
| ZOLL Circulation Inc | 1 | $139 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $127 |
| Veryan Medical Incorporated | 1 | $40 |
| Cordis US CORP. | 1 | $22 |
| Teleflex LLC | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Terumo Medical Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - STRUCTURAL HEART$3,125
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$1,532
- GENERAL VASCULAR ACCESS$900
- GENERAL - THERAPIES$834
- AVVIGO Guidance System$384
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$325
- Impella$249
- Indigo System$235
- Ultreon$225
- MitraClip$150
- Orsiro Mission$144
- PK Papyrus$144
- Zero Gravity$144
- COROFLOW$141
- SYNERGY$140
- TherOx DS2 Console$139
- Catheter$139
- Downstream Cartridge$139
- SYMPLICITY G3$128
- LifeVest$127
How this compares
$13,714 in reported general payments places this provider in the 60th percentile of 585 interventional cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 67 | $87,425 |
| EliquisApixaban | 61 | $81,665 |
| FarxigaDapagliflozin Propanediol | 51 | $44,712 |
| BrilintaTicagrelor | 26 | $21,572 |
| Repatha SureclickEvolocumab | 14 | $18,119 |
| JardianceEmpagliflozin | 11 | $16,329 |
| VascepaIcosapent Ethyl | 11 | $8,365 |
| Ranolazine ErRanolazine | 26 | $3,791 |
| Metoprolol Succinate | 184 | $2,103 |
| Atorvastatin Calcium | 216 | $1,784 |
| Losartan Potassium | 152 | $1,527 |
| Ezetimibe | 42 | $1,460 |
| ClopidogrelClopidogrel Bisulfate | 141 | $1,280 |
| Rosuvastatin Calcium | 50 | $857 |
| Carvedilol | 99 | $613 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Loma Linda
- Aditya BharadwajLoma Linda$380K
- Matthew Pricela Jolla$2.3M
- Frederick St GoarMountain View$2.2M
- Saibal KarThousand Oaks$1.1M
- Rahul SharmaStanford$1M
- Puneet KhannaRancho Mirage$1M
- Dennis SheehanRedwood City$900K
- Suhail DohadBeverly Hills$802K
- Curtiss Stinisla Jolla$759K
- Christian SpiesBurlingame$719K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.